ondansetron has been researched along with Cerebellar Diseases in 3 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebellar tremor is a frequent and disabling symptom in multiple sclerosis (MS) patients." | 6.70 | Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study. ( Buhmann, C; Gbadamosi, J; Heesen, C; Moench, A, 2001) |
| "Cerebellar dysfunction was quantified before and after treatment using the International Cooperative Ataxia Rating Scale (ICARS)." | 2.71 | Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study. ( Bier, JC; Dethy, S; Hildebrand, J; Jacquy, J; Manto, M; Martin, JJ; Seeldrayers, P, 2003) |
| "Cerebellar tremor is a frequent and disabling symptom in multiple sclerosis (MS) patients." | 2.70 | Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study. ( Buhmann, C; Gbadamosi, J; Heesen, C; Moench, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bier, JC | 1 |
| Dethy, S | 1 |
| Hildebrand, J | 1 |
| Jacquy, J | 1 |
| Manto, M | 1 |
| Martin, JJ | 1 |
| Seeldrayers, P | 1 |
| Rice, GP | 1 |
| Lesaux, J | 1 |
| Vandervoort, P | 1 |
| Macewan, L | 1 |
| Ebers, GC | 1 |
| Gbadamosi, J | 1 |
| Buhmann, C | 1 |
| Moench, A | 1 |
| Heesen, C | 1 |
3 trials available for ondansetron and Cerebellar Diseases
| Article | Year |
|---|---|
Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study.
Topics: Administration, Oral; Adolescent; Antiemetics; Cerebellar Diseases; Double-Blind Method; Drug Tolera | 2003 |
Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.
Topics: Cerebellar Diseases; Cross-Over Studies; Double-Blind Method; Humans; Injections, Intravenous; Ondan | 1997 |
Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study.
Topics: Adult; Cerebellar Diseases; Female; Humans; Injections, Intravenous; Male; Multiple Sclerosis; Ondan | 2001 |